CPhI South East Asia Indicates Rapid Pharma Sector Growth for the ASEAN

Amsterdam (ots/PRNewswire) -

Record numbers, a focus on development initiatives and analysis of
the

regional harmonisation programme helps stimulate increased
partnerships

CPhI, a division of UBM Live, announces that this year's recent
CPhI South East Asia 2013, which ran from 20-22nd March at the
Jakarta International Expo in Indonesia, was the most successful so
far. The event, which is the region's go to networking opportunity
and a hot bed of pharmaceutical innovation, attracted more than 5500
visitors from 51 countries and regions meeting over 260 exhibitors
from 25 countries and regions around the world.

The strong international focus at CPhI South East Asia is
representative of the expanding pharma sector within the region and
was enhanced by new co-located events, including: PMEC for
pharmaceutical machinery laboratory equipment and analytical
technology; and InnoPack South East Asia for innovative packaging and
drug delivery solutions.

"The pharma market in South East Asia is experiencing a very
dynamic period with growth of both domestic manufacturing and
international trade. We therefore designed CPhI South East Asia 2013
to reflect these sweeping changes and ran a series of high level
conferences alongside the exhibition enabling participants to hear
the latest thinking on pressing issues, including: the impending
ASEAN harmonisation due in 2015; cross-border trade and regulatory
arbitrage; IPR protection; and perspectives on the pharmerging
markets, regional consumer trends, the growth of generics and
regional manufacturing," commented Martin Wilson, UBM Live Brand
Director.

A crucial element of the ASEAN region's development, which is
predicted to reach a market value of US$80 billion by 2017, will be
the establishing of close regional partnerships and cross-sharing of
information between companies. CPhI South East Asia recognised this
evolving landscape and is the only dedicated event for the region
where ideas and business opportunities can be exchanged. Furthermore,
local Governments have lent their support to the event as they aim to
implement initiatives for increased domestic production particularly
focussed on generics and a tighter regulatory landscape aimed at
reducing anti-counterfeiting issues. Coupled with a growing economic
affluence and cross border trade means the region is at the precipice
of an explosion of growth.

The increase in exhibitors, internationally credible speakers and
visitors highlights the immense strides countries here have made in
manufacturing standards, increased commitment to standardised
regulation, improved packaging technologies, and legislation
protecting intellectual property - crucial to safeguarding innovation
- and improving safety standards.

Martin added: "CPhI as a whole is mirroring changes in South East
Asia and our aim is to help facilitate the adoption of new
technologies and partnerships needed to help meet the Government
backed demands of an increasing standardised regulatory arena and
greater domestic production of pharmaceuticals. With a rapidly
reforming healthcare landscape this event will continue to grow next
year and help build the region as a manufacturing base and source of
biotech and pharmaceutical innovation."

CPhI South East Asia will return to the Jakarta International Expo
from 20-22nd May 2014 and UBM Live looks forward to bringing its
international pharma event back to one of the world's most
dynamically evolving regions.

http://www.cphi-sea.com

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan ; CPhI, P-MEC,
ICSE, InnoPack and BioPh China (25-27 June, 2013 at the SNIEC in
Shanghai, China); CPhI, ICSE and BioPh South America (06-08 August,
2013 at the Expo Center Norte in Sao Paulo, Brazil); CPhI Worldwide,
ICSE, P-MEC Europe and InnoPack ; and CPhI and P-MEC India (03-05
December, 2013 at the Bombay Exhibition Centre in Mumbai).

Notes to the editor

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, China, India, Japan, Southeast
Asia, Russia and South America and co-locates with ICSE for contract
services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a
global community with news and analysis at PharmaEvolution.com,
produced by UBM Live and partners.

For more information visit: http://www.cphi.com

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745 E: a.heeley@defacto.com t.jervis@defacto.com

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de